Amgen To Present AT the Cowen 2nd Annual Virtual Oncology Innovation Summit

Rhea-AI Summary

Amgen will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit on May 21, 2021, at 11:20 a.m. ET. The presentation will be led by David M. Reese, M.D., Executive Vice President of Research and Development. A live audio broadcast will be available for media, investors, and the public. The webcast can be accessed on Amgen's website and will be available for replay for 90 days. Amgen focuses on delivering innovative human therapeutics to address significant medical needs.

THOUSAND OAKS, Calif., May 19, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit at 11:20 a.m. ET on Friday, May 21, 2021. David M. Reese, M.D., executive vice president of Research and Development at Amgen, will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Michael Strapazon, 805-313-5553 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-cowen-2nd-annual-virtual-oncology-innovation-summit-301295491.html

SOURCE Amgen

FAQ

What will Amgen present at the Cowen Oncology Innovation Summit on May 21, 2021?

Amgen will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit, focusing on its developments in oncology.

Who is presenting for Amgen at the Cowen Summit?

David M. Reese, M.D., Executive Vice President of Research and Development, will present.

What time does Amgen's presentation start at the Cowen Summit?

Amgen's presentation begins at 11:20 a.m. ET on May 21, 2021.

How can I watch Amgen's presentation at the Cowen Summit?

You can watch the presentation through a live audio broadcast available on Amgen's website.

Will the Amgen presentation be available after the event?

Yes, the webcast will be archived and available for replay for at least 90 days.

What is the focus of Amgen's research and development?

Amgen is committed to developing innovative therapeutics for serious illnesses, addressing high unmet medical needs.